BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 19880569)

  • 21. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus.
    Elkayam O; Paran D; Caspi D; Litinsky I; Yaron M; Charboneau D; Rubins JB
    Clin Infect Dis; 2002 Jan; 34(2):147-53. PubMed ID: 11740700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific antibody response after influenza immunization in systemic lupus erythematosus.
    Abu-Shakra M; Press J; Varsano N; Levy V; Mendelson E; Sukenik S; Buskila D
    J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen-specific antibody responses in lupus patients following immunization.
    Battafarano DF; Battafarano NJ; Larsen L; Dyer PD; Older SA; Muehlbauer S; Hoyt A; Lima J; Goodman D; Lieberman M; Enzenauer RJ
    Arthritis Rheum; 1998 Oct; 41(10):1828-34. PubMed ID: 9778224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
    Reichlin M; Broyles TF; Hubscher O; James J; Lehman TA; Palermo R; Stafford HA; Taylor-Albert E; Wolfson-Reichlin M
    Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Should we vaccinate patients with systemic lupus].
    Wiesik-Szewczyk E; Lacki JK; Chwalińiska-Sadowska H
    Pol Merkur Lekarski; 2007 Nov; 23(137):395-8. PubMed ID: 18361328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].
    Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Miroshnichenko NG; Samokishina NA; Serova AG; Nesterova SG
    Ter Arkh; 2006; 78(5):21-31. PubMed ID: 16889045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies in lupus nephritis patients requiring renal transplantation.
    Stinton LM; Barr SG; Tibbles LA; Yilmaz S; Sar A; Benedikttson H; Fritzler MJ
    Lupus; 2007; 16(6):394-400. PubMed ID: 17664229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
    Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
    Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Systemic lupus erythematosus and pregnancy].
    Haga HJ
    Tidsskr Nor Laegeforen; 1992 May; 112(14):1829-31. PubMed ID: 1631843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
    Bhat NM; Lee LM; van Vollenhoven RF; Teng NN; Bieber MM
    J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination and autoimmune rheumatic diseases.
    Conti F; Rezai S; Valesini G
    Autoimmun Rev; 2008 Dec; 8(2):124-8. PubMed ID: 18700175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic lupus erythematosus and renal transplantation. Report of two cases.
    Roenigk HH; Haserick JR; Nakamoto S; McCormack LJ
    Arch Dermatol; 1965 Sep; 92(3):263-70. PubMed ID: 11851247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus.
    Kuruma KA; Borba EF; Lopes MH; de Carvalho JF; Bonfá E
    Lupus; 2007; 16(5):350-4. PubMed ID: 17576737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fractional excretion magnesium (FE Mg) in systemic lupus erythematosus.
    Deekajorndech T
    J Med Assoc Thai; 2005 Jun; 88(6):743-5. PubMed ID: 16083212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
    Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
    Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination, atherosclerosis and systemic lupus erythematosus.
    Carvalho JF; Pereira RM; Shoenfeld Y
    Lupus; 2009 Nov; 18(13):1209-12. PubMed ID: 19880570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.